LUCIA SANCHEZ: Open Payments
NPI 1871256701 · LAREDO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$561 in 23 payments from 8 companies in 2025. Trend: 2023 $100 · 2024 $181 · 2025 $561
Food & beverage: $561
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $195 |
| Lilly USA, LLC | 7 | $185 |
| Sumitomo Pharma America, Inc. | 3 | $57 |
| Lundbeck LLC | 3 | $52 |
| Agios Pharmaceuticals, Inc. | 1 | $21 |
| SANOFI PASTEUR INC. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Amgen Inc. | 1 | $14 |
Products named: FARXIGA, KISUNLA, REXULTI, GEMTESA, BREZTRI, JARDIANCE, PYRUKYND, VAXELIS.
Industry payments across TX — which companies pay providers there.
